Decrinis M, Pilger E, Stark G, Lafer M, Obernosterer A, Lammer J
Department of Internal Medicine, Karl-Franzens-University School of Medicine Graz, Austria.
Eur Heart J. 1993 Mar;14(3):297-305. doi: 10.1093/eurheartj/14.3.297.
One-hundred and fifty patients with thrombotic and 60 patients with embolic occlusions of the superficial femoral and/or popliteal artery underwent a simplified IAT (intra-arterial thrombolysis) procedure. Ten mg rt-PA combined with 3000 IU Heparin were infused over 6 h, thereafter the extent of thrombolysis was checked fluoroscopically and the above mentioned treatment course repeated up to four times if necessary. The IAT regimen employed did not involve mechanical recanalization attempts; if complete thrombolysis revealed an underlying stenosis, a PTA (percutaneous transluminal angioplasty) was subsequently performed. IAT resulted in complete recanalization of 88 thrombotic occlusions (59%; 95% confidence interval: 50.8%-66.8%) and of 53 embolic occlusions (88%; 95% confidence interval: 77.1%-94.8% P < 0.001). In a further 33 (22%) thrombotic and four (7%) embolic occlusions IAT reduced the length of the occluded segment. At discharge, 102 (67%) patients with thrombotic and 55 (92%) patients with embolic occlusions were clinically improved. Overall, untoward effects occurred in 60 patients (29%): 47 (22%) were minor. Four patients (2%) suffered a systemic haemorrhage (three gastrointestinal, one macrohaematuria). The cumulative potency rate was significantly higher in patients with embolic occlusions throughout follow-up (82% vs 49% for thrombotic occlusions at 2 years, P < 0.001). Although all amputations were carried out in patients with thrombotic occlusions, follow-up mortality did not differ significantly between patients with embolic and thrombotic occlusions.
150例股浅动脉和/或腘动脉血栓形成患者以及60例栓塞性闭塞患者接受了简化的动脉内溶栓(IAT)治疗。将10mg重组组织型纤溶酶原激活剂(rt-PA)与3000IU肝素混合,在6小时内输注,之后通过荧光镜检查溶栓程度,如有必要,上述治疗过程可重复进行多达4次。所采用的IAT方案不涉及机械再通尝试;如果完全溶栓后发现存在潜在狭窄,则随后进行经皮腔内血管成形术(PTA)。IAT使88例血栓性闭塞(59%;95%置信区间:50.8%-66.8%)和53例栓塞性闭塞(88%;95%置信区间:77.1%-94.8%,P<0.001)实现完全再通。在另外33例(22%)血栓性闭塞和4例(7%)栓塞性闭塞中,IAT缩短了闭塞段的长度。出院时,102例(67%)血栓形成患者和55例(92%)栓塞性闭塞患者的临床症状得到改善。总体而言,60例患者(29%)出现了不良反应:47例(22%)为轻微不良反应。4例患者(2%)发生了全身性出血(3例为胃肠道出血,1例为肉眼血尿)。在整个随访期间,栓塞性闭塞患者的累积有效率显著更高(2年时,栓塞性闭塞患者为82%,血栓性闭塞患者为49%,P<0.001)。虽然所有截肢手术均在血栓性闭塞患者中进行,但栓塞性闭塞患者和血栓性闭塞患者的随访死亡率并无显著差异。